Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 | +$863M | |
| 2 | +$768M | |
| 3 | +$396M | |
| 4 |
Dollar General
DG
|
+$384M |
| 5 |
NVIDIA
NVDA
|
+$343M |
Top Sells
| 1 | +$2.09B | |
| 2 | +$988M | |
| 3 | +$964M | |
| 4 |
Spotify
SPOT
|
+$929M |
| 5 |
DoorDash
DASH
|
+$730M |
Sector Composition
| 1 | Consumer Discretionary | 30.9% |
| 2 | Technology | 26.6% |
| 3 | Communication Services | 19.74% |
| 4 | Healthcare | 8.44% |
| 5 | Financials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Norwegian Cruise Line
NCLH
$10.7B
| – | – |
-7,372,932
|
|
||
277
Neogen
NEOG
$1.29B
| – | – |
-9,158,876
|
|
||
278
Blue Owl Capital
OBDC
$6.58B
| – | – |
-551,430
|
|
||
279
Roku
ROKU
$14.5B
| – | – |
-2,489,007
|
|
||
280
SolarEdge
SEDG
$2.41B
| – | – |
-125,898
|
|
||
281
SiteOne Landscape Supply
SITE
$5.46B
| – | – |
-1,343,678
|
|
||
282
Sixth Street Specialty
TSLX
$2.06B
| – | – |
-373,254
|
|
||
|
ONC
283
BeOne Medicines Ltd
ONC
$34.7B
| – | – |
-3,630,710
|
|